Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Schließeit, Jana"'
Autor:
Asseyer, Susanna, Masuda, Hiroki, Mori, Masahiro, Bellmann-Strobl, Judith, Ruprecht, Klemens, Siebert, Nadja, Cooper, Graham, Chien, Claudia, Duchow, Ankelien, Schließeit, Jana, Liu, Jia, Sugimoto, Kazuo, Uzawa, Akiyuki, Ohtani, Ryohei, Paul, Friedemann, Brandt, Alexander U., Kuwabara, Satoshi, Zimmermann, Hanna G.
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background: Clinical outcomes in neuromyelitis optica spectrum disorders (NMOSD) vary across different regions. Objective: To describe clinical profiles in Japanese and German NMOSD patients. Methods: Medical records of aquaporin-4-immunoglobulin G (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9e5a9c8d7fd35a841be475a6769691
http://edoc.mdc-berlin.de/20279/1/20279oa.pdf
http://edoc.mdc-berlin.de/20279/1/20279oa.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Neurology
Neuromyelitis optica spectrum disorders (NMOSD) are mostly relapsing autoimmune inflammatory disorders of the central nervous system (CNS) with optic neuritis, myelitis, and brainstem syndromes as clinical hallmarks. With a reported prevalence of up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca0a2541fce537dd12aac85d19aef1a4
https://refubium.fu-berlin.de/handle/fub188/25586
https://refubium.fu-berlin.de/handle/fub188/25586
Autor:
Schließeit, Jana, Oertel, Frederike Cosima, Cooper, Graham, Brandt, Alexander U., Bellmann-Strobl, Judith
Publikováno v:
Acta Neurologica Belgica; Feb2021, Vol. 121 Issue 1, p271-274, 4p
Autor:
Asseyer S; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charite-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany NeuroCure Clinical Research Center, Charite- Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Bellmann-Strobl J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Ruprecht K; Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Siebert N; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Cooper G; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Chien C; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charite - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Duchow A; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charite - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Schließeit J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charite - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Sugimoto K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Paul F; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charite - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Brandt AU; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charite - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan., Zimmermann HG; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charite - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Publikováno v:
Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2021 May 04; Vol. 7 (2), pp. 20552173211006862. Date of Electronic Publication: 2021 May 04 (Print Publication: 2021).
Autor:
Oertel FC; NeuroCure Clinical Research Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Max-Delbrück-Centrum für Molekulare Medizin and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schließeit J; NeuroCure Clinical Research Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Max-Delbrück-Centrum für Molekulare Medizin and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands., Brandt AU; NeuroCure Clinical Research Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Max-Delbrück-Centrum für Molekulare Medizin and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology, University of California, Irvine, Irvine, CA, United States., Paul F; NeuroCure Clinical Research Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Max-Delbrück-Centrum für Molekulare Medizin and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Publikováno v:
Frontiers in neurology [Front Neurol] 2019 Jun 12; Vol. 10, pp. 608. Date of Electronic Publication: 2019 Jun 12 (Print Publication: 2019).